Total for this product: £87.92 + shipping
Lowest price in last 30 days before the discount: £87.92.
Our products are sold for professional use only.
Remember, if you are a professional from the EU, we will ask you for your VAT number at the checkout.
Supartz® is a non-surgical treatment used to relieve knee pain and improve mobility in patients with knee osteoarthritis.
The key ingredient in Supartz® is sodium hyaluronate, a natural component of synovial fluid that surrounds and cushions the joints. Once injected, it acts as a lubricant and shock absorber, helping to reduce pain and promote smoother movement in the joints. Over time, osteoarthritis leads to the deterioration of cartilage and a reduction in synovial fluid, causing inflammation, stiffness, and discomfort. Supartz® helps replenish the hyaluronan in the joints, reducing friction and easing the symptoms of osteoarthritis, allowing patients to return to daily activities with improved comfort and mobility.
Supartz® has been shown in clinical trials to offer significant pain relief and improved joint function for up to 12 months, with a low risk of side effects or complications. It is safe for both single and repeated treatments and carries a very low infection risk.
The injection process is quick, relatively painless, and more affordable compared to surgical alternatives. After each injection, doctors often recommend a physical therapy regimen to treat and help strengthen the knee and enhance long-term results.
This treatment is suitable for patients with knee pain and issues who have not found satisfactory relief through other pain management strategies (such as exercise, dietary changes, pain medications, or physical therapy). Acting as an orthopedic implant, Supartz® helps delay the necessity for surgical intervention by safeguarding cartilage and surrounding tissue. It diminishes friction and further damage while alleviating pain associated with joint grinding.
Supartz® is manufactured by Seikagaku Corporation, based in Japan.
Supartz® is composed of purified, viscoelastic hyaluronan derived from chicken combs and functions as a knee implant. After extraction, sodium hyaluronate undergoes purification to eliminate unwanted proteins, followed by the addition of a physiological buffer solution to create a viscoelastic gel. The straightforward and effective design of Supartz® packaging facilitates easy dosage adjustments to meet individual patient needs.
Each package of Supartz® contains 5×2.5ml prefilled containers and a package insert.
Store in the original packaging below 25°C (77°F). Do not freeze. The shelf life is 42 months; do not use after the expiration date.
The product should only be administered by trained and licensed professionals experienced in treating osteoarthritis through viscosupplementation.
Assess the patient’s medical history to determine suitability for Supartz® injections and establish the most effective plan. Factors such as the extent of joint damage, medications and supplements in use, and existing health issues should be considered.
Begin the procedure by disinfecting the injection site and removing any joint effusion. A local anaesthetic may be applied for increased comfort. The gel should be injected intra-articularly, directly into the affected joints, using one full 2.5ml syringe per knee. If both knees require treatment, separate syringes should be used.
While some patients may notice effects after just 3 injections, a full treatment course involves 5 weekly injections. Ensure that every step is performed aseptically to minimise infection and inflammatory reaction risks.
Following the Supartz® injection, patients should be advised to refrain from strenuous activities or weight-bearing exercises for 48 hours to avoid joint swelling. It is crucial to avoid standing for over an hour within the first 48 hours post-injection.
Ice packs and over-the-counter pain relievers may be recommended to manage any discomfort or swelling at the injection site. Physical therapy or rehabilitation exercises may also be suggested to maximise the benefits of Supartz® and promote joint strength and flexibility.
Regular follow-up appointments should be scheduled to monitor patient progress and address any concerns.
Supartz® can offer relief from pain and enhance functionality for up to 6-12 months, though individual responses may vary based on the patient’s condition. The regimen typically involves 3-5 injections of 2.5ml spaced a week apart, so full results may not be felt until after the third injection. Adhering to this schedule is crucial for optimal results.
Before initiating the process, patients should be informed about possible side effects related to the injections. Patients may experience:
Patients should rest the treated joints for at least 2 days after the procedure to lessen the severity of potential reactions. Advise patients to seek medical attention if any symptoms persist.
Administering Supartz® is not advised for individuals who:
Supartz® can only be purchased by licensed medical professionals, such as doctors and trained healthcare providers, who are authorised to administer it for treating knee osteoarthritis. It is essential for these professionals to obtain Supartz from reputable medical distributors or suppliers, such as the Nu Derma Supply shop, that specialise in providing professional-grade products to ensure safety and effectiveness in treatment.
Typically, a single Supartz® dose ranges from $290 to $330 for a 2.5ml syringe. As the procedure usually requires a series of 5 weekly injections, the total cost for the complete course can range from $1,450 to $1,635. Supartz® FX cost may fluctuate depending on the use of additional anaesthetics or other medical services.
Supartz® is a brand name for a purified form of hyaluronic acid(HA) known as sodium hyaluronate. It is utilised in a procedure called viscosupplementation, where the gel-like solution is injected into the knee to alleviate symptoms of osteoarthritis. While Supartz® contains HA, it is a specialised medical formulation specifically designed for joint relief.
Join our newsletter to receive latest news and offers
Medicle MD Ltd
Reg. Number: 14317237
Address: 27 Old Gloucester Street,
WC1N 3AX London,
United Kingdom